Molecular Biography (Post, April 7, 2004)

Loss Narrows for Reborn Celera (Post, July 24, 2003)

Md. Energy Project Gets Infusion: U.S. Boosts Funds for Effort to Find Alternative Power Sources (Post, April 25, 2003)

Celera Genomics Says Loss Narrowed as Revenue Fell (Post, Jan. 24, 2003)

Celera Aims to Crack The Code to Success: Gene Firm's Transition to Drug Developer Has Yet to Receive Wall St.'s Approval (Post, Jan. 21, 2003)

Nothing Wrong With A Little Frankenstein (Post, Dec. 1, 2002)

HGS Loss Tripled In Quarter: Biotech Firm Cites Drug-Trial Costs (Post, Oct. 30, 2002)

MedImmune, Celera News Shakes Sector (Post, Oct. 25, 2002)

Diagnostic Firms Ink Deals for Gene Tests (Post, Oct. 3, 2002)

Rockville On Venter's Gene Map (Post, Aug. 15, 2002)

Bio Pulse | Special Report
Can She Do It? (Washington Techway, Aug. 7, 2002; 7:59 AM)

Celera Narrows Its Loss in 4th Quarter (Post, July 26, 2002)

Patent Fight Erupts Over Gene Machine: Rival Challenges Firms on DNA Sequencer (Post, July 15, 2002)

Celera To Cut 132 Jobs, Refocus: Rockville Firm Shifts From Data to Drugs (Post, June 12, 2002)

Guiding Celera's Change: Venter Successor Kathy Ordoqez Faces Challenge (Post, May 9, 2002)

Life after Venter: At Celera Genomics, a new president and questions about the company's direction (Washington Techway, May 9, 2002; 10:58 AM)

Scientists Compile Map of Mouse's Genome: Placed in Public Domain, Data on Key Lab Animal Has Implications for Human Medical Research (Post, May 7, 2002)

A New Outlet for Venter's Energy: Genome Maverick To Take On Global Warming (Post, April 30, 2002)

Scientist Confirms Use Of Own DNA in Project: Celera Effort Included Founder's Genes (Post, April 28, 2002)